Integrative analysis of tumor stemness and immune microenvironment deciphers novel molecular subtypes in hepatocellular carcinoma.
作者信息
Wang Zhiyi, Chen Shuang, Li Dongxiao, Xu Hui, Weng Siyuan, Zhang Yuyuan, Ren Yuqing, Guo Chunguang, Li Xiuling, Liu Zaoqu, Han Xinwei
机构信息
Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan 450004, China.
出版信息
Genes Dis. 2023 Sep 7;11(5):101077. doi: 10.1016/j.gendis.2023.101077. eCollection 2024 Sep.
Abstract
摘要
相似文献
1
Integrative analysis of tumor stemness and immune microenvironment deciphers novel molecular subtypes in hepatocellular carcinoma.
Genes Dis. 2023 Sep 7;11(5):101077. doi: 10.1016/j.gendis.2023.101077. eCollection 2024 Sep.
2
Deep dissection of stemness-related hierarchies in hepatocellular carcinoma.
J Transl Med. 2023 Sep 16;21(1):631. doi: 10.1186/s12967-023-04425-8.
3
Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance.
J Transl Med. 2023 Nov 7;21(1):789. doi: 10.1186/s12967-023-04683-6.
4
Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
Front Immunol. 2024 Apr 17;15:1244392. doi: 10.3389/fimmu.2024.1244392. eCollection 2024.
5
mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes.
Comput Struct Biotechnol J. 2022 Jun 8;20:2928-2941. doi: 10.1016/j.csbj.2022.06.011. eCollection 2022.
6
Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma.
Discov Oncol. 2023 Nov 13;14(1):203. doi: 10.1007/s12672-023-00819-8.
7
KIF18B as a regulator in tumor microenvironment accelerates tumor progression and triggers poor outcome in hepatocellular carcinoma.
Int J Biochem Cell Biol. 2021 Aug;137:106037. doi: 10.1016/j.biocel.2021.106037. Epub 2021 Jul 1.
8
Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Pharmacol Res. 2020 Nov;161:105144. doi: 10.1016/j.phrs.2020.105144. Epub 2020 Aug 15.
9
Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
Biomed Res Int. 2022 Oct 5;2022:9168441. doi: 10.1155/2022/9168441. eCollection 2022.
10
Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.
Mod Pathol. 2016 Sep;29(9):1038-49. doi: 10.1038/modpathol.2016.111. Epub 2016 Jun 17.
引用本文的文献
1
The Role of MAPK12 in Prognosis of Patients With Liver Cancer and Effects on Stemness Characteristics.
Stem Cells Int. 2025 Aug 27;2025:9071464. doi: 10.1155/sci/9071464. eCollection 2025.
本文引用的文献
1
Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options.
Front Immunol. 2022 Jan 27;13:828330. doi: 10.3389/fimmu.2022.828330. eCollection 2022.
2
Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):26-44. doi: 10.1038/s41575-021-00508-3. Epub 2021 Sep 9.
3
A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma.
J Transl Med. 2021 Jan 6;19(1):5. doi: 10.1186/s12967-020-02697-y.
4
Goals and targets for personalized therapy for HCC.
Hepatol Int. 2019 Mar;13(2):125-137. doi: 10.1007/s12072-018-9919-1. Epub 2019 Jan 1.
5
Cancer stem cell definitions and terminology: the devil is in the details.
Nat Rev Cancer. 2012 Nov;12(11):767-75. doi: 10.1038/nrc3368. Epub 2012 Oct 11.
Zotero 插件